These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 22748813)

  • 1. Endolysins as antimicrobials.
    Nelson DC; Schmelcher M; Rodriguez-Rubio L; Klumpp J; Pritchard DG; Dong S; Donovan DM
    Adv Virus Res; 2012; 83():299-365. PubMed ID: 22748813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics.
    Rodríguez-Rubio L; Martínez B; Donovan DM; Rodríguez A; García P
    Crit Rev Microbiol; 2013 Nov; 39(4):427-34. PubMed ID: 22991936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications.
    Donovan DM
    Recent Pat Biotechnol; 2007; 1(2):113-22. PubMed ID: 19075835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking aim on bacterial pathogens: from phage therapy to enzybiotics.
    Hermoso JA; García JL; García P
    Curr Opin Microbiol; 2007 Oct; 10(5):461-72. PubMed ID: 17904412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage endolysins as a novel class of antibacterial agents.
    Borysowski J; Weber-Dabrowska B; Górski A
    Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci.
    Donovan DM; Foster-Frey J
    FEMS Microbiol Lett; 2008 Oct; 287(1):22-33. PubMed ID: 18673393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
    Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
    Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.
    Oliveira H; São-José C; Azeredo J
    Viruses; 2018 May; 10(6):. PubMed ID: 29844287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections.
    Gondil VS; Harjai K; Chhibber S
    Int J Antimicrob Agents; 2020 Feb; 55(2):105844. PubMed ID: 31715257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage endolysins as novel antimicrobials.
    Schmelcher M; Donovan DM; Loessner MJ
    Future Microbiol; 2012 Oct; 7(10):1147-71. PubMed ID: 23030422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Advantages and Challenges of Using Endolysins in a Clinical Setting.
    Murray E; Draper LA; Ross RP; Hill C
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33920965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel type of peptidoglycan-binding domain highly specific for amidated D-Asp cross-bridge, identified in Lactobacillus casei bacteriophage endolysins.
    Regulski K; Courtin P; Kulakauskas S; Chapot-Chartier MP
    J Biol Chem; 2013 Jul; 288(28):20416-26. PubMed ID: 23733182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysis of cells of diverse bacteria by l,d-peptidases of Escherichia coli bacteriophages RB43, RB49 and T5.
    Shadrin VS; Machulin AV; Dorofeeva LV; Chernyshov SV; Mikoulinskaia GV
    J Appl Microbiol; 2021 Jun; 130(6):1902-1912. PubMed ID: 33107183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.
    Walmagh M; Briers Y; dos Santos SB; Azeredo J; Lavigne R
    PLoS One; 2012; 7(5):e36991. PubMed ID: 22615864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure and function of modular Escherichia coli O157:H7 bacteriophage FTBEc1 endolysin, LysT84: defining a new endolysin catalytic subfamily.
    Love MJ; Coombes D; Ismail S; Billington C; Dobson RCJ
    Biochem J; 2022 Jan; 479(2):207-223. PubMed ID: 34935873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage endolysins: applications for food safety.
    Schmelcher M; Loessner MJ
    Curr Opin Biotechnol; 2016 Feb; 37():76-87. PubMed ID: 26707470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriophage lysins: progress and perspective--a review].
    Wang Y; Lu C
    Wei Sheng Wu Xue Bao; 2009 Oct; 49(10):1277-81. PubMed ID: 20069871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phage lytic enzymes--new hope in battle against bacterial infections].
    Niczyporuk JS; Bartoszcze M
    Przegl Epidemiol; 2007; 61(4):713-21. PubMed ID: 18572503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978.
    Lai MJ; Soo PC; Lin NT; Hu A; Chen YJ; Chen LK; Chang KC
    Int J Antimicrob Agents; 2013 Aug; 42(2):141-8. PubMed ID: 23742833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.